Susquehanna International Group, LLP Oramed Pharmaceuticals Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 91,027 shares of ORMP stock, worth $194,797. This represents 0.0% of its overall portfolio holdings.
Number of Shares
91,027
Previous 134,373
32.26%
Holding current value
$194,797
Previous $327,000
32.72%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding ORMP
# of Institutions
66Shares Held
8.11MCall Options Held
17.4KPut Options Held
19.5K-
Bml Capital Management, LLC Zionsville, IN2.64MShares$5.66 Million3.97% of portfolio
-
Murchinson Ltd. Toronto, A61.75MShares$3.75 Million2.03% of portfolio
-
Boothbay Fund Management, LLC New York, NY845KShares$1.81 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$784,0982.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$620,1780.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $83.1M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...